TipRanks
Go Ultimate55% OFF

Mettler-Toledo (MTD) Q2 2026 Earnings Report

MTD Q2 2026 EPS Results

Actual EPS
$11.46
Consensus EPS
$10.85
Beat/Miss
Beat by +$0.61
One Year Ago EPS
$10.09

MTD Q2 2026 Revenue Results

Actual Revenue
$1.03B
Expected Revenue
$1.03B
Beat/Miss
Missed by -$431.00K
YoY Revenue Growth
+4.48%

Earnings Announcement Details

Quarter
Q2 2026
Date
07/30/2026
Time
After Close
Conference Call
Thursday, July 30, 2026
MTD Upcoming Earnings

Mettler-Toledo's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

Q2 2026 Earnings Call Audio

MTD Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

Q2 2026 Earnings Call Summary

Q2 2026
Earnings Call Date:Jul 30, 2026|% Change Since:21.31%|
Earnings Call Sentiment|Positive

The call conveyed a decidedly positive operational and financial picture: revenue growth beat expectations, margins expanded, adjusted EPS rose ~14% and full-year guidance was raised. Strength was broad-based (China, emerging markets, Lab, Industrial automation, services) and driven by pricing, productivity initiatives (Spinnaker) and product innovation. Notable risks and noise included one-time tariff refund accounting that reduced reported sales, timing-related weakness in Product Inspection and certain projects, EU chemical exposure to energy costs, higher transportation costs, and short backlog that increases near-term sensitivity. On balance, management presented confidence in execution and raised guidance, indicating momentum into the second half despite identifiable near-term risks.

Company Guidance

The company raised its full‑year 2026 guidance, now calling for local‑currency sales growth of approximately 4%–5% (organic 3%–4%) excluding the one‑time tariff refunds, with adjusted EPS guidance of $47.15–$47.50 (up ~10%–11%, or ~11%–12% excluding currency); at recent spot rates FX is estimated to be a ~1% benefit to sales and a slight headwind to EPS. For Q3 2026 the company expects local‑currency sales growth of ~4% (including ~0.5% from acquisitions) and adjusted EPS of $12.00–$12.15 (up ~8%–9%, or ~9%–10% excluding currency); currency is expected to be neutral to Q3 sales and a ~1% headwind to Q3 EPS. Additional 2026 assumptions: total amortization ~$78M (purchased intangibles ~$28M pretax, ≈$1.07), interest expense ~$67M, other income ~$24M, effective tax rate ~19%, free cash flow ~ $900M (≈6% growth per share), and share repurchases increased to $875M for the year (vs. $825M annualized in H1).

  • Top-Line Growth Outperformed ExpectationsQ2 sales were $1.0B, up 7% in USD and 6% in local currency; organic local-currency sales growth was 4% and acquisitions contributed ~1.5%.
  • Strong Regional Performance — China and Emerging MarketsAsia/Rest of World organic growth was +9% (China +9%); emerging markets outside China represented ~18% of sales and grew high single digits in the quarter.
  • Broad-Based Product Strength — Lab, Industrial, Food Retail, ServiceLaboratory organic sales +4%; Core Industrial +4% (Industrial overall +3%); Food Retail +11%; Service revenue +9% (7% organically), with service continuing to outgrow product sales.
  • Margin Expansion and ProfitabilityAdjusted gross margin 59.3% (up 30 bps); excluding FX and acquisitions gross margin expanded ~90 bps. Adjusted operating margin 29.3% (up 50 bps vs prior year; +100 bps excluding currency).
  • Earnings Per Share and Operating Profit GrowthAdjusted operating profit $309M (+9% YoY). Adjusted EPS $11.46 (+14% YoY). Reported EPS $11.55 vs $9.76 a year ago (reported included one-time tariff impacts).
  • Raised Full-Year GuidanceFull-year local-currency sales growth increased to ~4–5% (organic 3–4%). Adjusted EPS guidance raised to $47.15–$47.50 (10–11% growth; 11–12% ex-currency), up from prior 8–10% range.
  • Solid Cash Flow and Capital Return PlansAdjusted free cash flow YTD $367M; full-year free cash flow expected ~ $900M (~6% per-share growth). Share repurchases increased to $875M for the full year (vs $825M annualized first half).
  • Execution Drivers — Spinnaker, Productivity and InnovationManagement cites Spinnaker sales/marketing program, productivity initiatives and recent product innovation (e.g., LabX, new balances, pipettes) as key drivers of growth, pricing power (~3% price realization in Q2) and margin expansion.

MTD Earnings History

MTD earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 05, 20262026 (Q3)12.12-11.15――
Jul 30, 20262026 (Q2)10.8511.4610.0913.58% (+1.37)
May 07, 20262026 (Q1)8.718.918.198.79% (+0.72)
Feb 05, 20262025 (Q4)12.8013.3612.417.66% (+0.95)
Nov 06, 20252025 (Q3)10.6611.1510.219.21% (+0.94)
Jun 30, 20252025 (Q2)9.6010.099.654.56% (+0.44)
May 01, 20252025 (Q1)7.888.198.89-7.87% (-0.70)
Feb 06, 20252024 (Q4)11.7212.419.432.02% (+3.01)
Nov 07, 20242024 (Q3)10.0110.219.84.18% (+0.41)
Aug 01, 20242024 (Q2)9.039.6510.19-5.30% (-0.54)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed
Show More